Related Experiment Videos
Mitral valve prolapse: from syndrome to disease
1Department of Medicine, Francis Scott Key Medical Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21224.
The American Journal of Cardiology
|December 28, 1987
Summary
Mitral valve prolapse (MVP) is often benign, but can be linked to autonomic dysfunction and anxiety symptoms. Research suggests MVP and anxiety disorders may not be directly linked, despite shared symptoms.
Area of Science:
- Cardiology
- Psychiatry
Background:
- Mitral valve prolapse (MVP) encompasses diverse conditions affecting the mitral valve apparatus.
- While often benign, MVP can progress to mitral insufficiency or predispose to bacterial endocarditis.
- MVP is frequently associated with a syndrome including autonomic dysfunction and symptoms like chest pain, palpitations, and anxiety.
Purpose of the Study:
- To investigate the relationship between mitral valve prolapse and associated symptoms.
- To explore the potential link between MVP and anxiety disorders.
- To clarify the association between the severity of MVP and the degree of autonomic dysfunction or symptom severity.
Main Methods:
- Review of existing literature on mitral valve prolapse and associated conditions.
- Analysis of studies examining the co-occurrence of MVP and anxiety disorders.
- Correlation analysis between MVP severity, autonomic dysfunction, and symptom reporting.
Main Results:
- The risk of severe complications in MVP relates to patient sex, age, and prolapse severity.
- Little to no correlation exists between the extent of prolapse and the degree of autonomic dysfunction or symptom severity.
- Recent studies suggest that MVP and anxiety disorders are not directly linked, despite symptom overlap.
Conclusions:
- MVP is a heterogeneous condition with varying clinical implications.
- The association between MVP and anxiety disorders requires further clarification, with current evidence suggesting no direct link.
- Iatrogenic cardiac neurosis is a common finding in patients with MVP and anxiety disorders.